OXFORD BIOMEDICA (OXB): MODERATED CHART AND DISCUSSION THREAD

"...but what is this rise based on?"

This Co's valuation should be underpinned by talent, fundamental technical innovation and hard graft - over many, many years. Let's celebrate that.

OXB is on every scanner in the City. Leading health and Pharma Insts all over the world now know all about OXB. This valuation is not based on speculative hot air but real substance: TroVax SPA, Orphan status, PIII trials, one of the most exciting and diverse neurology pipelines in the market. Enjoy the re-rate in the run up to OXB's first O/L deal of the year. They'll be more......regrettably ;o)